Best adjuvant (assist) for chemotherapy | 1+1>487% | Effectively improve chemotherapy effect, treatment, immunity. Reduce side effects and recurrence. Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract / Summary / Overview of Apoptosis.
Why do cells undergo apoptosis?
The relationship between cancer cells and apoptosis.
Where are the weaknesses and symptoms of cancer cells?
Are cancer cells aggressive?
Extraordinary Solamargine (Role, Principle, Action, Mechanism, Function, Work)
Solamargine 's major function mechanism:
Solamargine vs cancer
Best Chemotherapy Adjuvant (1+1>478%)
Effectively improve chemotherapy effect and cure.
When cancer cells are less resistant to drugs, chemotherapy becomes more effective.
Extract : https://www.cancer.gov/types/ovarian/patient/ovarian-low-malignant-treatment-pdq
Ovarian Low Malignant Potential Tumors Treatment General Information About Ovarian Low Malignant Potential Tumors KEY POINTS Ovarian low malignant potential tumor is a disease in which abnormal cells form in the tissue covering the ovary. Signs and symptoms of ovarian low malignant potential tumor include pain or swelling in the abdomen. Tests that examine the ovaries are used to diagnose and stage ovarian low malignant potential tumor. Certain factors affect prognosis (chance of recovery) and treatment options.
Abstract / Summary / Overview of Apoptosis.
Overview of apoptosis
•Programmed cell death
•Apoptosis is a form of programmed cell death, or “cellular suicide.”
•Apoptosis is different from necrosis, in which cells die due to injury.
•Apoptosis removes cells during development, eliminates potentially cancerous and virus-infected cells, and maintains balance in the body.
Why do cells undergo apoptosis? Basically, apoptosis is a general and convenient way to remove cells that should no longer be part of the organism. Some cells are abnormal and could hurt the rest of the organism if they survive, such as cells with viral infections or DNA damage. Apoptosis is part of development In many organisms, programmed cell death is a normal part of development.
The relationship between cancer cells and apoptosis Apoptosis can eliminate infected or cancerous cells.
When a cell’s DNA is damaged, it will typically detect the damage and try to repair it.
If the damage is beyond repair, the cell will normally send itself into apoptosis, ensuring that it will not pass on its damaged DNA.
When cells have DNA damage but fail to undergo apoptosis, they may be on the road to cancer.
However, “successful” cancer cells successfully evade the process of apoptosis.
This allows them to divide out of control and accumulate mutations (changes in their DNA).
Apoptosis is key to immune function
Apoptosis also plays an essential role in the development and maintenance of a healthy immune system.
Where are the weaknesses and symptoms of cancer cells? The symptoms of cancer cells are in the nucleus.
The nucleus controls the outer cytoplasm, cell composition, cell viability, etc.
DNA mutations also mutate in the nucleus.
Therefore, to treat cancer cells, we must first enter the nucleus.
Let the “regulatory cell gene” mechanism enter the nucleus to regulate
Are cancer cells aggressive? After the action of Solamargine , the aggressiveness of cancer cells is alleviated.
So after using Solamargine , many patients feel that I am half better.
Although the tumor does not disappear quickly, patients feel that the degree of aggressiveness is reduced.
Extraordinary Solamargine (Role, Principle, Action, Mechanism, Function, Work).
Solamargine 's major function mechanism:
When Solamargine enter, Solamargine activates receptors that are turned off by cancer cells, allowing cancer cells to modulate again. Solamargine modulates the anti-modulates genes of cancer cells, making cancer cells less resistant. Reduced drug resistance When cancer cells are less resistant to drugs, chemotherapy becomes more effective. Solamargine modulates the mutated genes in cancer cells and then initiates cancer cell apoptosis to achieve anti-cancer effects.
Solamargine combined with which chemotherapy drugs are more effective in treating cancer cells?
Solamargine vs cancer
Solamargine vs cancer The picture shows the death of cancer cells.
The black and black parts are cancer cell nuclei.
Even if the nucleus ruptures, the cancer cells will die.
The figure shows that cancer cells can cause death.
The figure shows that cancer cells can cause death.
The figure shows that the death of lung cancer cells is relatively slow, and it will not be obvious until eight hours later.
The figure shows that the death of liver cancer cells is very obvious, even more obvious in eight hours.
The graph shows that breast cancer cells die faster. It was obvious from the beginning that breast cancer is easy to treat, and patients with breast cancer need not worry.
Best Chemotherapy Adjuvant (1+1>487%) Effectively improve chemotherapy effect and treatment. ANTI-CANCER Patent protection in 32 nations. A comparison study showing Solamargine vs. other therapeutic drugs with respect to lung cancer cells. A comparison study showing Solamargine vs. other chemotherapeutic drugs with respect to breast cancer cells.
SR-T100 combination therapy with effective result against breast cancer cells.
Combination Therapy | Research results for lung cancer cells. A. Chemotherapy (100μM), 16% of cancer cell apoptosis. B. Alone SM (4.8μM), 28% of cancer cell apoptosis. C. SM (4.80μM) + Chemotherapy (40μM), 66% of cancer cells apoptosis. D. SM (4.80μM) + Chemotherapy (100μM), 78% of cancer cell apoptosis. SM has a clearing effect better than Chemotherapy . The combined treatment of Solamargine and Chemotherapy significantly increased the apoptosis of lung cancer cells. SM (4.8μ M) + Chemotherapy (40μM), increased from 16% to 66% (up to 4.125 times). SM (4.8μM) + Chemotherapy (100μM), increased from 16% to 78% (up to 4.875 times). Reorganized from: BBRC. Action of Solamargine on TNFs and drug-resistant human lung cancer cells 2004.
Solamargine Q&A (English)
survival rate | cancer | Contents survival rate | cancer | Etymology and definitions survival rate | cancer | Signs and symptoms survival rate | cancer | Local symptoms survival rate | cancer | Systemic symptoms survival rate | cancer | Metastasis survival rate | cancer | Causes survival rate | cancer | Chemicals survival rate | cancer | Diet and exercise survival rate | cancer | Infection survival rate | cancer | Radiation survival rate | cancer | Heredity survival rate | cancer | Physical agents survival rate | cancer | Hormones survival rate | cancer | Autoimmune diseases survival rate | cancer | Pathophysiology survival rate | cancer | Genetics survival rate | cancer | Epigenetics survival rate | cancer | Metastasis survival rate | cancer | Metabolism survival rate | cancer | Diagnosis survival rate | cancer | Classification survival rate | cancer | Prevention survival rate | cancer | Dietary survival rate | cancer | Medication survival rate | cancer | Vaccination survival rate | cancer | Screening survival rate | cancer | Recommendations survival rate | cancer | Genetic testing survival rate | cancer | Management survival rate | cancer | Cancer survival rate | cancer | Radiation survival rate | cancer | Surgery survival rate | cancer | Palliative care survival rate | cancer | Immunotherapy survival rate | cancer | Laser therapy survival rate | cancer | Alternative medicine survival rate | cancer | Prognosis survival rate | cancer | Epidemiology survival rate | cancer | History survival rate | cancer | Society and culture survival rate | cancer | Economic effect survival rate | cancer | Workplace survival rate | cancer | Research survival rate | cancer | Pregnancy survival rate | cancer | Other animals survival rate | cancer | Notes survival rate | cancer | Further reading survival rate | cancer | External links Ovarian low malignant potential tumor | survival rate | Contents Ovarian low malignant potential tumor | survival rate | Etymology and definitions Ovarian low malignant potential tumor | survival rate | Signs and symptoms Ovarian low malignant potential tumor | survival rate | Local symptoms Ovarian low malignant potential tumor | survival rate | Systemic symptoms Ovarian low malignant potential tumor | survival rate | Metastasis Ovarian low malignant potential tumor | survival rate | Causes Ovarian low malignant potential tumor | survival rate | Chemicals Ovarian low malignant potential tumor | survival rate | Diet and exercise Ovarian low malignant potential tumor | survival rate | Infection Ovarian low malignant potential tumor | survival rate | Radiation Ovarian low malignant potential tumor | survival rate | Heredity Ovarian low malignant potential tumor | survival rate | Physical agents Ovarian low malignant potential tumor | survival rate | Hormones Ovarian low malignant potential tumor | survival rate | Autoimmune diseases Ovarian low malignant potential tumor | survival rate | Pathophysiology Ovarian low malignant potential tumor | survival rate | Genetics Ovarian low malignant potential tumor | survival rate | Epigenetics Ovarian low malignant potential tumor | survival rate | Metastasis Ovarian low malignant potential tumor | survival rate | Metabolism Ovarian low malignant potential tumor | survival rate | Diagnosis Ovarian low malignant potential tumor | survival rate | Classification Ovarian low malignant potential tumor | survival rate | Prevention Ovarian low malignant potential tumor | survival rate | Dietary Ovarian low malignant potential tumor | survival rate | Medication Ovarian low malignant potential tumor | survival rate | Vaccination Ovarian low malignant potential tumor | survival rate | Screening Ovarian low malignant potential tumor | survival rate | Recommendations Ovarian low malignant potential tumor | survival rate | Genetic testing Ovarian low malignant potential tumor | survival rate | Management Ovarian low malignant potential tumor | survival rate | Chemotherapy Ovarian low malignant potential tumor | survival rate | Radiation Ovarian low malignant potential tumor | survival rate | Surgery Ovarian low malignant potential tumor | survival rate | Palliative care Ovarian low malignant potential tumor | survival rate | Immunotherapy Ovarian low malignant potential tumor | survival rate | Laser therapy Ovarian low malignant potential tumor | survival rate | Alternative medicine Ovarian low malignant potential tumor | survival rate | Prognosis Ovarian low malignant potential tumor | survival rate | Epidemiology Ovarian low malignant potential tumor | survival rate | History Ovarian low malignant potential tumor | survival rate | Society and culture Ovarian low malignant potential tumor | survival rate | Economic effect Ovarian low malignant potential tumor | survival rate | Workplace Ovarian low malignant potential tumor | survival rate | Research Ovarian low malignant potential tumor | survival rate | Pregnancy Ovarian low malignant potential tumor | survival rate | Other animals Ovarian low malignant potential tumor | survival rate | Notes Ovarian low malignant potential tumor | survival rate | Further reading Ovarian low malignant potential tumor | survival rate | External links